Swedish biotech companies have a broad and varied product pipeline that is attracting attention from venture capitalists and pharmaceutical companies.
|Articles|December 2, 2003
- Pharmaceutical Technology-12-02-2003
- Volume 27
- Issue 12
Sixth Annual International Employment Survey: Staying the Course
Author(s)Maribel Rios
Despite continued industry-wide layoffs in manufacturing jobs during the past year, the pharmaceutical industry workforce continues a slow and steady pace.
Advertisement
Articles in this issue
almost 23 years ago
December 2003almost 23 years ago
All Signs Indicate a Strong 2004 for Contract Servicesalmost 23 years ago
Behavior of Uptake of Moisture by Drugs and Excipientsalmost 23 years ago
Targeted Cationic Liposomes, Technologies, and Developmentsalmost 23 years ago
Drug Pricing Concerns Shape Policy Decisions in 2003almost 23 years ago
In the Spotlight--January 2004almost 23 years ago
December 2003Advertisement
Related to this article
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
2
PharmTech’s Weekly Roundup—September 25, 2026
3
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
4
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
5